Literature DB >> 16385373

Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome.

Wang-Huei Sheng1, Bor-Luen Chiang, Shan-Chwen Chang, Hung-Nern Ho, Jann-Tay Wang, Yee-Chun Chen, Cheng-Hsiang Hsiao, Po-Ren Hseuh, Wei-Chu Chie, Pan-Chyr Yang.   

Abstract

BACKGROUND AND
PURPOSE: Severe acute respiratory syndrome (SARS) is a highly transmissible disease with significant morbidity and mortality. Death from SARS is most often due to rapidly progressive respiratory compromise (acute respiratory distress syndrome, ARDS) and subsequent multi-organ dysfunction. However, the mechanisms evoking respiratory distress and a fulminant systemic response remain unclear. In order to elucidate the pathogenic mechanisms of SARS, we analyzed clinical manifestations and levels of serum cytokines of SARS patients.
METHODS: Fourteen hospitalized patients with a diagnosis of SARS-associated coronavirus infection at National Taiwan University Hospital from March to May 2003 were included. Data on clinical manifestations, parameters of laboratory tests, complications and final outcomes of patients were collected retrospectively. Serial plasma inflammatory cytokines, including interleukin (IL)-1beta (IL-1beta), IL-6, IL-8 and tumor necrosis factor-alpha (TNF-alpha) of preserved serum were measured by enzyme immunoassay.
RESULTS: All 14 patients had fever, dry cough and dyspnea. Twelve were intubated during hospitalization. The median duration from onset of fever to the nadir level or most severe condition was 9 days for hypoxia, 7 days for lymphocytopenia, 6.5 days for thrombocytopenia, 9.5 days for maximal pulmonary infiltrates; to peak serum levels was 9 days for C-reactive protein (CRP), 10.5 days for IL-6, 13.5 days for IL-8 and 12 days for TNF-alpha; to defervescence was 13 days. There was no significant elevation of serum IL-1beta levels in any of the 14 patients. There were no significant differences in peak levels of IL-6, IL-8 and TNF-alpha between patients with and without ARDS. The 8 patients who died tended to have higher peak levels of serum TNF-alpha compared to those who survived (14 vs 9.1 pg/mL; p = 0.06).
CONCLUSION: Rapid elevation of inflammatory cytokines-IL-6, IL-8 and TNF-alpha might play a role in the development of SARS-related ARDS. The timing of elevations in inflammatory cytokines and CRP is correlated with progression of pulmonary infiltrates of SARS patients. The peak level of serum TNF-alpha tends to be higher in patients who die of SARS than in those who survive. Our results indicate that CRP and TNF-alpha might be used as prognostic markers of SARS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385373

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  28 in total

1.  Serum cytokine responses in primary pneumonic plague patients.

Authors:  Xiaoyi Wang; Zuyun Wang; Zhaobiao Guo; Baiqing Wei; Fuzhang Tian; Shouhong Yu; Haoran Wang; Hu Wang; Ruifu Yang
Journal:  Clin Vaccine Immunol       Date:  2010-11-24

2.  Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay.

Authors:  Jun-Jun Yeh; Shih-Hueh Syue; Yi-Fun Sun; Yi-Ting Yeh; Ya-Chi Zheng; Cheng-Li Lin; Chung Y Hsu; Chia-Hung Kao
Journal:  Biomedicines       Date:  2022-05-31

3.  C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection.

Authors:  Ofer Zimmerman; Ori Rogowski; Galit Aviram; Michal Mizrahi; David Zeltser; Dan Justo; Esther Dahan; Roy Arad; Oholi Touvia; Luba Tau; Jalal Tarabeia; Shlomo Berliner; Yael Paran
Journal:  BMC Infect Dis       Date:  2010-10-04       Impact factor: 3.090

4.  Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.

Authors:  Barry Rockx; Davide Corti; Eric Donaldson; Timothy Sheahan; Konrad Stadler; Antonio Lanzavecchia; Ralph Baric
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

5.  Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.

Authors:  Barry Rockx; Timothy Sheahan; Eric Donaldson; Jack Harkema; Amy Sims; Mark Heise; Raymond Pickles; Mark Cameron; David Kelvin; Ralph Baric
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

6.  Yeast based small molecule screen for inhibitors of SARS-CoV.

Authors:  Matthew Frieman; Dipanwita Basu; Krystal Matthews; Justin Taylor; Grant Jones; Raymond Pickles; Ralph Baric; Daniel A Engel
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

7.  Immunologic changes during Pandemic (H1N1) 2009, China.

Authors:  Hong-Hui Shen; Jun Hou; Wei-Wei Chen; Bing-Ke Bai; Hai-Bin Wang; Tong-Sheng Guo; Ai-Xia Liu; Yong-Li Li; Min Zhao; Pan-Yong Mao; Jin Li; Bo-An Li; Yuan Li-Mao
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

8.  Serum diamine oxidase as a hemorrhagic shock biomarker in a rabbit model.

Authors:  Liang Zhao; Lin Luo; Weikun Jia; Juan Xiao; Gang Huang; Geng Tian; Jingwei Li; Yingbin Xiao
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

9.  Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.

Authors:  Lu Qin; Xiaochen Li; Jing Shi; Muqing Yu; Ke Wang; Yu Tao; Ying Zhou; Min Zhou; Shuyun Xu; Bo Wu; Zhenyu Yang; Cong Zhang; Junqing Yue; Chongsheng Cheng; Xiansheng Liu; Min Xie
Journal:  J Med Virol       Date:  2020-06-19       Impact factor: 20.693

10.  The landscape of cognitive function in recovered COVID-19 patients.

Authors:  Hetong Zhou; Shaojia Lu; Jingkai Chen; Ning Wei; Dandan Wang; Hailong Lyu; Chuan Shi; Shaohua Hu
Journal:  J Psychiatr Res       Date:  2020-06-30       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.